Literature DB >> 27382019

Infectivity of Plasmodium falciparum in Malaria-Naive Individuals Is Related to Knob Expression and Cytoadherence of the Parasite.

Danielle I Stanisic1, John Gerrard2, James Fink2, Paul M Griffin3, Xue Q Liu1, Lana Sundac2, Silvana Sekuloski4, Ingrid B Rodriguez1, Jolien Pingnet1, Yuedong Yang1, Yaoqi Zhou1, Katharine R Trenholme4, Claire Y T Wang5, Hazel Hackett5, Jo-Anne A Chan6, Christine Langer6, Eric Hanssen7, Stephen L Hoffman8, James G Beeson6, James S McCarthy9, Michael F Good10.   

Abstract

Plasmodium falciparum is the most virulent human malaria parasite because of its ability to cytoadhere in the microvasculature. Nonhuman primate studies demonstrated relationships among knob expression, cytoadherence, and infectivity. This has not been examined in humans. Cultured clinical-grade P. falciparum parasites (NF54, 7G8, and 3D7B) and ex vivo-derived cell banks were characterized. Knob and knob-associated histidine-rich protein expression, CD36 adhesion, and antibody recognition of parasitized erythrocytes (PEs) were evaluated. Parasites from the cell banks were administered to malaria-naive human volunteers to explore infectivity. For the NF54 and 3D7B cell banks, blood was collected from the study participants for in vitro characterization. All parasites were infective in vivo However, infectivity of NF54 was dramatically reduced. In vitro characterization revealed that unlike other cell bank parasites, NF54 PEs lacked knobs and did not cytoadhere. Recognition of NF54 PEs by immune sera was observed, suggesting P. falciparum erythrocyte membrane protein 1 expression. Subsequent recovery of knob expression and CD36-mediated adhesion were observed in PEs derived from participants infected with NF54. Knobless cell bank parasites have a dramatic reduction in infectivity and the ability to adhere to CD36. Subsequent infection of malaria-naive volunteers restored knob expression and CD36-mediated cytoadherence, thereby showing that the human environment can modulate virulence.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27382019      PMCID: PMC4995910          DOI: 10.1128/IAI.00414-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Plasmodium falciparum: cytoadherence of a knobless clone.

Authors:  B A Biggs; J G Culvenor; J S Ng; D J Kemp; G V Brown
Journal:  Exp Parasitol       Date:  1989-08       Impact factor: 2.011

2.  A chromosomal rearrangement in a P. falciparum histidine-rich protein gene is associated with the knobless phenotype.

Authors:  L G Pologe; J V Ravetch
Journal:  Nature       Date:  1986 Jul 31-Aug 6       Impact factor: 49.962

3.  Pathogenicity, stability, and immunogenicity of a knobless clone of Plasmodium falciparum in Colombian owl monkeys.

Authors:  S G Langreth; E Peterson
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

4.  Cytoadherence of knobless Plasmodium falciparum-infected erythrocytes and its inhibition by a human monoclonal antibody.

Authors:  R Udomsangpetch; M Aikawa; K Berzins; M Wahlgren; P Perlmann
Journal:  Nature       Date:  1989-04-27       Impact factor: 49.962

5.  Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.

Authors:  David J Pombo; Gregor Lawrence; Chakrit Hirunpetcharat; Christine Rzepczyk; Michelle Bryden; Nicole Cloonan; Karen Anderson; Yuvadee Mahakunkijcharoen; Laura B Martin; Danny Wilson; Salenna Elliott; Suzanne Elliott; Damon P Eisen; J Brice Weinberg; Allan Saul; Michael F Good
Journal:  Lancet       Date:  2002-08-24       Impact factor: 79.321

6.  Comparative infectivity of knobless and knobby clones of Plasmodium falciparum in splenectomized and intact Aotus trivirgatus monkeys.

Authors:  H N Lanners; W Trager
Journal:  Z Parasitenkd       Date:  1984

7.  A real-time, quantitative PCR method using hydrolysis probes for the monitoring of Plasmodium falciparum load in experimentally infected human volunteers.

Authors:  Rebecca J Rockett; Sarah J Tozer; Chris Peatey; Seweryn Bialasiewicz; David M Whiley; Michael D Nissen; Katharine Trenholme; James S Mc Carthy; Theo P Sloots
Journal:  Malar J       Date:  2011-02-28       Impact factor: 2.979

8.  Knob-independent cytoadherence of Plasmodium falciparum to the leukocyte differentiation antigen CD36.

Authors:  B A Biggs; L Goozé; K Wycherley; D Wilkinson; A W Boyd; K P Forsyth; L Edelman; G V Brown; J H Leech
Journal:  J Exp Med       Date:  1990-06-01       Impact factor: 14.307

9.  Development of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccines.

Authors:  Danielle I Stanisic; Xue Q Liu; Sai Lata De; Michael R Batzloff; Tanya Forbes; Christopher B Davis; Silvana Sekuloski; Marina Chavchich; Wendy Chung; Katharine Trenholme; James S McCarthy; Tao Li; B Kim Lee Sim; Stephen L Hoffman; Michael F Good
Journal:  Malar J       Date:  2015-04-07       Impact factor: 2.979

10.  Establishment of the 1st World Health Organization International Standard for Plasmodium falciparum DNA for nucleic acid amplification technique (NAT)-based assays.

Authors:  David J Padley; Alan B Heath; Colin Sutherland; Peter L Chiodini; Sally A Baylis
Journal:  Malar J       Date:  2008-07-24       Impact factor: 2.979

View more
  9 in total

Review 1.  Controlled Human Malaria Infection: Applications, Advances, and Challenges.

Authors:  Danielle I Stanisic; James S McCarthy; Michael F Good
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

Review 2.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

3.  Live Vaccination with Blood-Stage Plasmodium yoelii 17XNL Prevents the Development of Experimental Cerebral Malaria.

Authors:  Takashi Imai; Ha Ngo-Thanh; Kazutomo Suzue; Aoi Shimo; Akihiro Nakamura; Yutaka Horiuchi; Hajime Hisaeda; Takashi Murakami
Journal:  Vaccines (Basel)       Date:  2022-05-11

4.  Human vaccination against RH5 induces neutralizing antimalarial antibodies that inhibit RH5 invasion complex interactions.

Authors:  Ruth O Payne; Sarah E Silk; Sean C Elias; Kazutoyo Miura; Ababacar Diouf; Francis Galaway; Hans de Graaf; Nathan J Brendish; Ian D Poulton; Oliver J Griffiths; Nick J Edwards; Jing Jin; Geneviève M Labbé; Daniel Gw Alanine; Loredana Siani; Stefania Di Marco; Rachel Roberts; Nicky Green; Eleanor Berrie; Andrew S Ishizuka; Carolyn M Nielsen; Martino Bardelli; Frederica D Partey; Michael F Ofori; Lea Barfod; Juliana Wambua; Linda M Murungi; Faith H Osier; Sumi Biswas; James S McCarthy; Angela M Minassian; Rebecca Ashfield; Nicola K Viebig; Fay L Nugent; Alexander D Douglas; Johan Vekemans; Gavin J Wright; Saul N Faust; Adrian Vs Hill; Carole A Long; Alison M Lawrie; Simon J Draper
Journal:  JCI Insight       Date:  2017-11-02

5.  In Vitro Variant Surface Antigen Expression in Plasmodium falciparum Parasites from a Semi-Immune Individual Is Not Correlated with Var Gene Transcription.

Authors:  Ellen Inga Bruske; Sandra Dimonte; Corinna Enderes; Serena Tschan; Matthias Flötenmeyer; Iris Koch; Jürgen Berger; Peter Kremsner; Matthias Frank
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

6.  Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria Parasites.

Authors:  Leanne M Low; Aloysious Ssemaganda; Xue Q Liu; Mei-Fong Ho; Victoria Ozberk; James Fink; Lana Sundac; Kylie Alcorn; Amy Morrison; Kevin O'Callaghan; John Gerrard; Danielle I Stanisic; Michael F Good
Journal:  Infect Immun       Date:  2018-12-19       Impact factor: 3.441

7.  Different Life Cycle Stages of Plasmodium falciparum Induce Contrasting Responses in Dendritic Cells.

Authors:  Xi Zen Yap; Rachel J Lundie; Gaoqian Feng; Joanne Pooley; James G Beeson; Meredith O'Keeffe
Journal:  Front Immunol       Date:  2019-01-31       Impact factor: 7.561

8.  Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria.

Authors:  Stephen D Woolley; Louise Marquart; John Woodford; Stephan Chalon; Joerg J Moehrle; James S McCarthy; Bridget E Barber
Journal:  Malar J       Date:  2021-12-20       Impact factor: 2.979

9.  Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study.

Authors:  Danielle I Stanisic; James Fink; Johanna Mayer; Sarah Coghill; Letitia Gore; Xue Q Liu; Ibrahim El-Deeb; Ingrid B Rodriguez; Jessica Powell; Nicole M Willemsen; Sai Lata De; Mei-Fong Ho; Stephen L Hoffman; John Gerrard; Michael F Good
Journal:  BMC Med       Date:  2018-10-08       Impact factor: 8.775

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.